
Mark T. Henderson
Examiner (ID: 5127)
| Most Active Art Unit | 3722 |
| Art Unit(s) | 3722 |
| Total Applications | 519 |
| Issued Applications | 301 |
| Pending Applications | 35 |
| Abandoned Applications | 183 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18965258
[patent_doc_number] => 11899015
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-02-13
[patent_title] => Chimeric recombinant proteins and recombinant protein panels for the diagnosis of Lyme disease in animals and humans
[patent_app_type] => utility
[patent_app_number] => 18/049022
[patent_app_country] => US
[patent_app_date] => 2022-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 16
[patent_no_of_words] => 17939
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 234
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18049022
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/049022 | Chimeric recombinant proteins and recombinant protein panels for the diagnosis of Lyme disease in animals and humans | Oct 23, 2022 | Issued |
Array
(
[id] => 17792482
[patent_doc_number] => 20220251573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => RECOMBINANT MICROORGANISMS AND USES THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/650191
[patent_app_country] => US
[patent_app_date] => 2022-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18367
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17650191
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/650191 | Recombinant microorganisms and uses therefor | Feb 6, 2022 | Issued |
Array
(
[id] => 17937082
[patent_doc_number] => 11471514
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-10-18
[patent_title] => Dual-enzyme composition for preventing, treating and/or alleviating veisalgia and symptoms associated therewith
[patent_app_type] => utility
[patent_app_number] => 17/557046
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 4857
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17557046
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/557046 | Dual-enzyme composition for preventing, treating and/or alleviating veisalgia and symptoms associated therewith | Dec 20, 2021 | Issued |
Array
(
[id] => 17502552
[patent_doc_number] => 20220095654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => GROUND MEAT REPLICAS
[patent_app_type] => utility
[patent_app_number] => 17/531460
[patent_app_country] => US
[patent_app_date] => 2021-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22633
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17531460
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/531460 | Ground meat replicas | Nov 18, 2021 | Issued |
Array
(
[id] => 18545498
[patent_doc_number] => 11718839
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-08-08
[patent_title] => Compositions and methods for deactivating enveloped viruses such as SARS-CoV-2
[patent_app_type] => utility
[patent_app_number] => 17/378358
[patent_app_country] => US
[patent_app_date] => 2021-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 13
[patent_no_of_words] => 9428
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17378358
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/378358 | Compositions and methods for deactivating enveloped viruses such as SARS-CoV-2 | Jul 15, 2021 | Issued |
Array
(
[id] => 17067626
[patent_doc_number] => 20210269841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => ENDO-S2 MUTANTS AS GLYCOSYNTHASES, METHOD OF MAKING AND USE FOR GLYCOENGINEERING OF GLYCOPROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/320703
[patent_app_country] => US
[patent_app_date] => 2021-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15942
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17320703
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/320703 | Endo-S2 mutants as glycosynthases, method of making and use for glycoengineering of glycoproteins | May 13, 2021 | Issued |
Array
(
[id] => 17307534
[patent_doc_number] => 11208631
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-12-28
[patent_title] => Dual-enzyme composition for preventing, treating and/or alleviating veisalgia and symptoms associated therewith
[patent_app_type] => utility
[patent_app_number] => 17/308995
[patent_app_country] => US
[patent_app_date] => 2021-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2473
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17308995
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/308995 | Dual-enzyme composition for preventing, treating and/or alleviating veisalgia and symptoms associated therewith | May 4, 2021 | Issued |
Array
(
[id] => 18051759
[patent_doc_number] => 11525132
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-13
[patent_title] => Ligase mutant
[patent_app_type] => utility
[patent_app_number] => 17/210094
[patent_app_country] => US
[patent_app_date] => 2021-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 11609
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17210094
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/210094 | Ligase mutant | Mar 22, 2021 | Issued |
Array
(
[id] => 17649909
[patent_doc_number] => 11352623
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => Methods and compositions for directed genome editing
[patent_app_type] => utility
[patent_app_number] => 17/206526
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 67
[patent_no_of_words] => 49774
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 320
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17206526
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/206526 | Methods and compositions for directed genome editing | Mar 18, 2021 | Issued |
Array
(
[id] => 16992194
[patent_doc_number] => 20210230614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => FERMENTATIVE GLYCEROL-FREE ETHANOL PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 17/176073
[patent_app_country] => US
[patent_app_date] => 2021-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11255
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17176073
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/176073 | Fermentative glycerol-free ethanol production | Feb 14, 2021 | Issued |
Array
(
[id] => 17221998
[patent_doc_number] => 11174489
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-16
[patent_title] => Fermentative glycerol-free ethanol production
[patent_app_type] => utility
[patent_app_number] => 17/176040
[patent_app_country] => US
[patent_app_date] => 2021-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 11503
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17176040
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/176040 | Fermentative glycerol-free ethanol production | Feb 14, 2021 | Issued |
Array
(
[id] => 18685401
[patent_doc_number] => 11781124
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-10
[patent_title] => Recombinant polynucleotide sequence for producing astaxanthin and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/094623
[patent_app_country] => US
[patent_app_date] => 2020-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 72
[patent_figures_cnt] => 72
[patent_no_of_words] => 20613
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 199
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17094623
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/094623 | Recombinant polynucleotide sequence for producing astaxanthin and uses thereof | Nov 9, 2020 | Issued |
Array
(
[id] => 17126499
[patent_doc_number] => 20210301267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => COMPOSITIONS AND METHODS FOR USING GENETICALLY MODIFIED ENZYMES
[patent_app_type] => utility
[patent_app_number] => 17/081724
[patent_app_country] => US
[patent_app_date] => 2020-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43847
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17081724
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/081724 | COMPOSITIONS AND METHODS FOR USING GENETICALLY MODIFIED ENZYMES | Oct 26, 2020 | Abandoned |
Array
(
[id] => 17845135
[patent_doc_number] => 11434491
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-06
[patent_title] => Compositions and methods for gene editing
[patent_app_type] => utility
[patent_app_number] => 17/073588
[patent_app_country] => US
[patent_app_date] => 2020-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 63
[patent_no_of_words] => 33959
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17073588
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/073588 | Compositions and methods for gene editing | Oct 18, 2020 | Issued |
Array
(
[id] => 16762658
[patent_doc_number] => 20210108239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => PROCESS
[patent_app_type] => utility
[patent_app_number] => 17/074607
[patent_app_country] => US
[patent_app_date] => 2020-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18174
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17074607
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/074607 | Processes to make neosaxitoxin and analogues thereof | Oct 18, 2020 | Issued |
Array
(
[id] => 16916353
[patent_doc_number] => 20210189445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => Benzylisoquinoline Alkaloids (BIA) Producing Microbes, and Methods of Making and Using the Same
[patent_app_type] => utility
[patent_app_number] => 17/069066
[patent_app_country] => US
[patent_app_date] => 2020-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31432
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17069066
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/069066 | Benzylisoquinoline alkaloids (BIA) producing microbes, and methods of making and using the same | Oct 12, 2020 | Issued |
Array
(
[id] => 16614958
[patent_doc_number] => 20210033611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => METHODS AND COMPOUNDS FOR DIAGNOSING THREONYL-tRNA SYNTHETASE-ASSOCIATED DISEASES AND CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 17/067728
[patent_app_country] => US
[patent_app_date] => 2020-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29829
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17067728
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/067728 | Methods and compounds for diagnosing threonyl-tRNA synthetase-associated diseases and conditions | Oct 10, 2020 | Issued |
Array
(
[id] => 16525547
[patent_doc_number] => 20200399627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => ENGINEERED PHENYLALANINE AMMONIA LYASE POLYPEPTIDES
[patent_app_type] => utility
[patent_app_number] => 17/009925
[patent_app_country] => US
[patent_app_date] => 2020-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37395
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 255
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17009925
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/009925 | Engineered phenylalanine ammonia lyase polypeptides | Sep 1, 2020 | Issued |
Array
(
[id] => 17783011
[patent_doc_number] => 11406107
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-09
[patent_title] => Compositions comprising recombinant bacillus cells and another biological control agent
[patent_app_type] => utility
[patent_app_number] => 16/935020
[patent_app_country] => US
[patent_app_date] => 2020-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 31598
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 206
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16935020
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/935020 | Compositions comprising recombinant bacillus cells and another biological control agent | Jul 20, 2020 | Issued |
Array
(
[id] => 17742833
[patent_doc_number] => 11390890
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-19
[patent_title] => Dibasic organic acid producing strain and preparation and application of same
[patent_app_type] => utility
[patent_app_number] => 16/933327
[patent_app_country] => US
[patent_app_date] => 2020-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 16344
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 368
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16933327
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/933327 | Dibasic organic acid producing strain and preparation and application of same | Jul 19, 2020 | Issued |